ClinicalTrials.Veeva

Menu

Laparoscopic Ovarian Drilling Versus Letrozole In Clomiphene Citrate Resistant Polycystic Ovary

A

Ain Shams University

Status and phase

Unknown
Phase 3

Conditions

Induction of Ovulation

Treatments

Drug: group A 2.5 mg letrozole oral tablets
Procedure: laparoscopic ovarian drilling

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this work is to compare the clinical outcomes of letrozole with laparoscopic ovarian drilling (LOD) in patients with clomiphene-citrate-resistant polycystic ovary syndrome (PCOS).

Enrollment

90 estimated patients

Sex

Female

Ages

20 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients diagnosed as PCOS according to Roterdam (2003) criteria
  2. patients with Clomiphene resistance, i.e. failure to ovulate following 100 mg CC for 5 days for at least three cycles.
  3. patent fallopian tubes, confirmed by hysterosalpingography or hysteroscopic diagnosis.
  4. normal semen analysis parameters of the patients' spouses according to the modified criteria of the World Health Organization.
  5. normal serum prolactin, thyroid stimulating hormone and 17-OH progesterone.
  6. no systemic disease; no gonadotropin or other hormonal drug treatment during the preceding 3 months.

Exclusion criteria

1- Infertility induced by reasons other than PCOS. 2- uterine cavity lesions or ovarian cyst. 3- >40 years old. 4- body mass index (BMI) >26 kg/m2. 5- contraindications to general anesthesia. 6- history of pelvic surgery. 7- other endocrine diseases. 8- a history of liver or kidney disease.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

90 participants in 2 patient groups

Group A Letrozole group
Experimental group
Description:
2.5 mg letrozole oral tablets will be administered on the 2nd -3rd day of menses and then every day for 5 days.
Treatment:
Drug: group A 2.5 mg letrozole oral tablets
Group B laparoscopic ovarian drilling group
Active Comparator group
Description:
bilateral laparoscopic ovarian drilling, each ovary will be cauterized at 4 points, each for 4 sec at 40 W, at a depth of 7-8 mm and a diameter of 3-5 mm, using a monopolar electrosurgical needle according to the size of each ovary.
Treatment:
Procedure: laparoscopic ovarian drilling

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed Abdelshafy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems